MESA, ARIZONA / ACCESS Newswire / October 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of advanced healthcare AI solutions, today announced that it has secured access to the International Skin Imaging Collaboration (ISIC) Archive – one of the world’s largest publicly available, biopsy-verified image repositories for skin cancer and related dermatological conditions.
The ISIC Archive contains more than 70,000 high-quality, expertly annotated dermoscopic images, representing a wide range of skin tones, cancer subtypes, and benign conditions. This unprecedented data resource will serve as a foundation for training MDCE’s proprietary AI software designed to detect and classify melanoma and other skin cancers at a level approaching clinical accuracy.
“The medical AI community has long recognized the ISIC Archive as a gold standard for dermatology research,” said Marshall Perkins III, CEO of Medical Care Technologies. “By leveraging this highly respected and globally validated dataset, MDCE is advancing its mission to make early detection of skin cancer faster, more accurate, and more accessible worldwide.”
Skin cancer is the most common cancer globally, with more than 1.5 million new cases diagnosed each year. Early detection dramatically improves patient outcomes, but access to dermatologists and specialized diagnostic tools remains limited in many parts of the world.
MDCE’s development program is currently focused on integrating the ISIC data into its machine learning pipeline, with additional collaborations under review to further expand the diversity and scope of training images.
This milestone positions Medical Care Technologies to progress toward future clinical trials, regulatory pathways, and eventual commercialization of its AI-driven diagnostic platform.
Company Website: www.medicalcaretechnologies.com
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC Pink:MDCE) is a healthcare technology company dedicated to developing innovative medical software solutions that improve early disease detection and patient care outcomes. The company is currently advancing an artificial intelligence platform for skin cancer and dermatological condition identification.
Safe Harbor Statement
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on current expectations, projections, and assumptions that involve risks and uncertainties which may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
Atropos Health is integrating the American Society of Clinical Oncology® (ASCO®) Guidelines into their platform…
PLANO, Texas, Dec. 5, 2025 /PRNewswire/ -- Teams playing in the StaffDNA® Cure Bowl were…
IRVINE, Calif., Dec. 5, 2025 /PRNewswire/ -- The Dot Corp has expanded its services with…
CHICAGO, Dec. 5, 2025 /PRNewswire/ -- Vaniam Group™, a category leader redefining medical communications, announced…
The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory…
Results confirm reproducibility and research readiness for islet isolation of Biorep's next generation laboratory platform.MIAMI,…